Isoniazid - new formulation (oral liquid) - EMLc

被引：0
|
作者：
机构：
来源：
SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN) | 2019年 / 1021卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：109 / 113
页数：5
相关论文
共 50 条
  • [31] FORMULATION OF A READILY PREPARED D-PENICILLAMINE ORAL LIQUID
    RAWLINS, DA
    SMITH, JM
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1982, 7 (02): : 141 - 143
  • [32] GRADUAL ORAL DESENSITIZATION TO ISONIAZID
    HOWLAND, NR
    LEE, TM
    BLUMBERG, HM
    MORGAN, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 241 - 241
  • [33] Oral local drug delivery and new perspectives in oral drug formulation
    Paderni, Carlo
    Compilato, Domenico
    Giannola, Libero Italo
    Campisi, Giuseppina
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2012, 114 (03): : E25 - E34
  • [34] Rapid oral desensitisation to isoniazid
    Epozturk, K.
    Atayik, E.
    Abadoglu, O.
    ALLERGY, 2011, 66 : 608 - 609
  • [35] CONTROLLED-RELEASE TABLET FORMULATION OF ISONIAZID
    JAIN, NK
    KULKARNI, K
    TALWAR, N
    PHARMAZIE, 1992, 47 (04): : 277 - 278
  • [36] Development of oral sustained-release formulation of isoniazid/alginate/chitosan-blend microspheres for intestinal delivery
    Samad, A.
    Sultana, Y.
    Khar, R. K.
    Aqil, M.
    Misha, A. K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 : A53 - A54
  • [37] SANDIMMUN NEORAL PHARMACOKINETICS - IMPACT OF THE NEW ORAL FORMULATION
    HOLT, DW
    MUELLER, EA
    KOVARIK, JM
    VANBREE, JB
    RICHARD, F
    KUTZ, K
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1434 - 1437
  • [38] NEW APPROACH FOR PRE-FORMULATION OF AN ORAL CYCLOSPORINE
    Boukhris, T.
    Lahiani-Skiba, M.
    Bounoure, F.
    Skiba, M.
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2012, 7 (01) : 155 - 164
  • [39] Neurologic oral manifestations caused by a new formulation of mirtazapine
    Kling, A
    Dahlqvist, R
    Johansson, S
    Bäckström, M
    Mjörndal, T
    NEUROLOGY, 2005, 65 (02) : 333 - 334
  • [40] DISTRIBUTION AND EXCRETION OF A NEW ORAL FORMULATION OF DOCETAXEL IN MICE
    Soo, Byoung
    Yoon, Doo Hyun
    Choi, Tae Hyun
    Kang, Joo Hyun
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S31 - S31
12345